0000899243-23-005550.txt : 20230217 0000899243-23-005550.hdr.sgml : 20230217 20230217192322 ACCESSION NUMBER: 0000899243-23-005550 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230215 FILED AS OF DATE: 20230217 DATE AS OF CHANGE: 20230217 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Nazak Michael Adrian CENTRAL INDEX KEY: 0001799731 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41331 FILM NUMBER: 23644753 MAIL ADDRESS: STREET 1: 5941 OPTICAL COURT CITY: SAN JOSE STATE: CA ZIP: 95138 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AN2 Therapeutics, Inc. CENTRAL INDEX KEY: 0001880438 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 820606654 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1800 EL CAMINO REAL, SUITE D CITY: MENLO PARK STATE: CA ZIP: 94027 BUSINESS PHONE: (650) 331-9090 MAIL ADDRESS: STREET 1: 1800 EL CAMINO REAL, SUITE D CITY: MENLO PARK STATE: CA ZIP: 94027 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-02-15 0 0001880438 AN2 Therapeutics, Inc. ANTX 0001799731 Nazak Michael Adrian C/O AN2 THERAPEUTICS, INC. 1800 EL CAMINO REAL, SUITE D MENLO PARK CA 94027 0 1 0 0 Chief Accounting Officer Stock Option (right to buy) 14.29 2023-02-15 4 A 0 16600 0.00 A 2033-02-14 Common Stock 16600 16600 D The shares subject to the option vest as follows: 1/48 of the shares shall vest on each monthly anniversary as measured from January 1, 2023. /s/ Lucy Day, Attorney-in-Fact for Michael Adrian Nazak 2023-02-17